Aneeq Waqar, MD
Interventional Cardiology · Springfield, ILNPI 1477075943
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.0%), food and beverage and education — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 63.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $2,084 and has fallen 85.7% since, to $298 in 2025. That places this record below the midpoint for interventional cardiology clinicians in IL, where the typical reported total is $7,434.
Across 24 payments — averaging $113.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2K
- Abiomed$430
- Medtronic$164
- Abbott$149
- Sanofi-aventis U.S. LLC$73
- Chiesi USA, Inc.$72
- plus $119 from 2 others
What the payments were for
- Travel & lodging$1,33949%
- Food & beverage$1,23145%
- Education$1656%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 15 | $1,729 |
| Abiomed | 3 | $430 |
| Medtronic | 1 | $164 |
| Abbott | 1 | $149 |
| Sanofi-aventis U.S. LLC | 1 | $73 |
| Chiesi USA, Inc. | 1 | $72 |
| Boston Scientific | 1 | $71 |
| Penumbra, Inc. | 1 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,736 in reported general payments places this provider in the 25th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $11,795 |
| ClopidogrelClopidogrel Bisulfate | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Springfield
- Tony de MartiniSpringfield$208K
- Shady HenienSpringfield$105K
- Donald YakelSpringfield$54K
- Jack HallSpringfield$40K
- Krishna Rocha SinghSpringfield$25K
- Andrei PopElk Grove Village$900K
- Atman ShahChicago$788K
- Ravi RamanaPalos Park$458K
- Mahesh RajuDowners Grove$281K
- Mark RicciardiEvanston$253K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.